23andMe Raises $79.1M in Private Financing

NEW YORK (GenomeWeb) – 23andMe has raised $79.1 million of a targeted $150 million in a private financing, according to a document filed with the US Securities and Exchange Commission.

In a filing with the SEC on July 2, 23andMe said it is seeking to raise $150 million through the sale of Series E Preferred Stock. It said that it made the first sale of stock in the round on June 18.

The firm said that 15 investors have participated in the round so far, but it did not disclose the names of those investors.

In March, the firm launched a therapeutics group headed by former Genentech executive Richard Scheller. And earlier this year, it received clearance from the US Food and Drug Administration to market its first health-related test, for Bloom syndrome, directly to consumers.




11,579 thoughts on “23andMe Raises $79.1M in Private Financing

  1. Its like you read my mind! You seem to know so much about this,
    like you wrote the book in it or something. I think that you could do with
    a few pics to drive the message home a bit, but other than that, this is excellent
    blog. A fantastic read. I’ll definitely be back.

  2. Hi there to all, how is everything, I think every one is getting more from this website, and your views
    are good in support of new people.

  3. At thiѕ time it looks like WordPress is thе top blogɡing platform out there гigҺt now.
    (from what I’ѵe гead) Is that what yοu’re using on your
    blog?

  4. I think this is among the most important information for me.
    And i’m glad studying your article. However want to commentary on few basic things, The site style is wonderful, the articles is really excellent : D.
    Good process, cheers

Leave a Reply

Your email address will not be published.